Comparison of the effects of class I anti-arrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 5, 1996, Pages 893-903

  Wang, Dao Wu ^a   Kiyosue, Tatsuto ^a   Sato, Toshiaki ^a   Arita, Makoto ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Action potential duration; Cibenzoline; Delayed rectifier K+ current; E4031; Flecainide; Guinea pig ventricular myocytes; Mexiletine

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM ION; CIBENZOLINE; FLECAINIDE; MEXILETINE; NITRENDIPINE; POTASSIUM ION;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; GUINEA PIG; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART VENTRICLE WALL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; VOLTAGE CLAMP;

EID: 0029941571     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0084     Document Type: Article

References (28)

1. BALSER JR, BENNETT PB, HONDEGHEM LM, RODEN DM, 1991. Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of Quinidine and amiodarone. Circ Res 69: 519-529.
2. + current in rabbit ventricular myocytes. Cardiovasc Drugs Ther 7: 599-604.
3. DANGMAN KH, 1984. Cardiac effects of cibenzoline. J Cardiovasc Pharmacol 6: 300-311.
4. K, by flecainide and E4031 in cat ventricular myocytes. Circulation 82: 289-293.
5. FOLLMER CH, CULLINAN CA, COLATSKY JT, 1992. Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: evidence for open channel block and unblock. Cardiovasc Res 26: 1121-1130.
6. HARRON DWG, BROGDEN RN, FAULDS D, FITTON A, 1992. Cibenzoline: a review of its pharmacological properties and therapeutic potential in arrhythmias. Drugs 43: 734-759.
7. HOFFMANN E, MATTKE S, HABERL R, STEINBECK G, 1993. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia. J Cardiovasc Pharmacol 21: 95-100.
8. 2+ inward current by the class I antiarrhythmic agent, cibenzoline. Br J Pharmacol 87: 705-711.
9. KOTAKE H, MATSUOKA S, OGINO K, YAKAMI T, HASEGAWA J, MASHIBA H, 1987. Electrophysiological study of cibenzoline in voltage-clamped rabbit sinoatrial node preparations. J Pharmac Exp Ther 241: 982-986.
10. LYNCH JJ, WILBER DJ, MONTGOMERY DG, HSEIH TM, PATTERSON E, LUCCHESI BR, 1984. Antiarrhythmic and antifibrillatory actions of the levo-and dextrorotatory isomers of sotalol. J Cardiovasc Pharmacol 6: 1132-1141.
11. MARTY A, NEHER E, 1983. Tigh t-seal whole-cell recording. In: B. Sakmann and E Neher (eds) Single-Channel Recordings. Plenum Press, New York, 107-122.
12. MASSE C, CAZES M, SASSINE A, 1984. Effects of cibenzoline, a novel antiarrhythmic drug, on action potential and transmembrane currents in frog atrial muscle. Arch Int Pharmacodyn 269: 219-235.
13. NOBLE D, TSIEN RW, 1969. Outward membrane currents activated in the plateau range of potential in cardiac Purkinje fibres. J Physiol (Lond) 200: 205-231.
14. ONO K, KIYOSUE T, ARITA M, 1986. Comparison of the inhibitory effects of lidocaine and mexiletine on the calcium current of single ventricular cells. Life Sci 39: 1465-1470.
15. K activation in guinea pig ventricular myocytes. Circ Res 62: 1055-1058.
16. + current: differential sensitivity to block by Class III antiarrhythmic agents. J Gen Physiol 96: 195-215.
17. + current is composed of two currents in guinea pig atrial cells. Am J Physiol 260: H393-H399.
18. + channels. Br J Pharmacol 115: 381-382.
19. SATO T, WU B, KIYOSUE T, ARITA M, 1994. Effects of cibenzoline, a new class Ia antiarrhythmic drug, on various membrane ionic currents and action potentials of guinea-pig ventricular cells. Naunyn-Schmiedeberg's Arch Pharmacol 350: 167-173.
20. Ca in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin. Am J Physiol 256: C549-C559.
21. + channel blocking actions of flecainide compared to those of propafenone and quinidine in adult rat ventricular myocytes. J Pharmac Exp Ther 269: 66-74.
22. TANIGUCHI J, KOKUBUN S, NOMA A, IRISAWA H, 1981. Spontaneously active cells isolated from the sino-atrial and atrio-ventricular nodes of rabbit heart. Jpn J Physiol 31: 547-558.
23. VAUGHAN-WILLIAMS EM, 1984. A classification of antiarrhythmic action reassessed after a decade of new drugs. J Clin Pharmacol 24: 129-141.
24. VAUGHAN-WILLIAMS EM, 1992. Classifying antiarrhythmic actions: By facts or speculation. J Clin Pharmacol 32: 964-977.
25. + channels by flecainide in guinea-pig ventricular cells. Cardiovasc Res 29: 520-525.
26. WETTWER E, GRUNDKE M, RAVENS U, 1992. Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes. Cardiovasc Res 26: 1145-1152.
27. WU B, SATO T, KIYOSUE T, ARITA M, 1992. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs. Cardiovasc Res 26: 1095-1101.
28. ZIPES DP, TROUP PJ, 1978. New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil. Am J Cordiol 41: 1005-1025.